sulfamethazine has been researched along with Bright Disease in 2 studies
Sulfamethazine: A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
sulfamethazine : A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Milejski, P | 1 |
| Orzechowska-Juzwenko, K | 1 |
| Strychowski, J | 1 |
| Szewczyk, Z | 1 |
| Klinger, M | 1 |
| Williams, DM | 1 |
| Wimpenny, J | 1 |
| Asscher, AW | 1 |
2 other studies available for sulfamethazine and Bright Disease
| Article | Year |
|---|---|
[Acetylation phenotype in glomerulonephritis and its clinical significance].
Topics: Acetylation; Adolescent; Adult; Aged; Disease Susceptibility; Female; Glomerulonephritis; Humans; Ma | 1987 |
Renal clearance of sodium sulphadimidine in normal and uraemic subjects.
Topics: Adolescent; Adult; Chronic Disease; Diuresis; Female; Glomerular Filtration Rate; Glomerulonephritis | 1968 |